The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...
MyChesCo on MSN3h
Johnson & Johnson Highlights Promising Data on Investigational Autoantibody Drug NipocalimabJohnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback